Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

CRISPR/Cas9 Multi-Editing Enhances CAR NK Cells Therapeutic Potential Against Multiple Myeloma

Blood (2024) 144 (Supplement 1): 3442.

https://doi.org/10.1182/blood-2024-207942

Published: 2024

Journal Articles

Enhanced Antitumoral Efficacy of ARI0002h CAR-T with CD28-TMD in Normal and Low BCMA Expressing Myeloma Cells

Luis Gerardo Rodríguez-Lobato, Oriol Cardus, Joan Mañé Pujol, Anthony Battram, David F. Moreno, Lorena Perez-Amill, Beatriz Martín-Antonio, Aina Oliver-Caldés, Anna De Daniel, Natalia Tovar, M Teresa Cibeira López, Laura Rosinol Dachs, Manel Juan, Alvaro Urbano-Ispizua, Carlos Fernández de Larrea

Blood (2024) 144 (Supplement 1): 359.

https://doi.org/10.1182/blood-2024-200123

Published: 2024

Journal Articles

ARI0002h (Cesnicabtagene Autoleucel), an Academic Point-of-Care B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor (CAR) T-Cell Strategy: Activity and Safety after Fractionated Initial Therapy and Booster Dose in 60 Patients with Relapsed/Refractory Multiple Myeloma

Blood (2023) 142 (Supplement 1): 1026.

https://doi.org/10.1182/blood-2023-180828

Published: 2023

Journal Articles

Bicistronic CAR T Cell Against CD229 and BCMA Effectively Controls Multiple Myeloma

Blood (2022) 140 (Supplement 1): 10281–10282.

https://doi.org/10.1182/blood-2022-166764

Published: 2022

Journal Articles

Co-Transduced CD19/BCMA Dual-Targeting CAR-T Cells for the Treatment of Non-Hodgkin Lymphoma

Mireia Bachiller, Cèlia Dobaño-López, Alba Rodríguez-García, Joan Castellsagué, Marta Gimenez-Alejandre, Asier Antoñana-Vildosola, Beatriz Martin-Antonio, Julio Delgado, Patricia Pérez-Galán, Manel Juan, Álvaro Urbano-Ispizua, Sonia Guedan

Blood (2022) 140 (Supplement 1): 7386–7387.

https://doi.org/10.1182/blood-2022-168651

Published: 2022

Journal Articles

CAR-T Related Cytopenia Profile in Relapsed/Refractory Multiple Myeloma: Results of Patients Treated with ARI0002h, an Academic BCMA-Directed CAR-T Cell

Blood (2022) 140 (Supplement 1): 10347–10349.

https://doi.org/10.1182/blood-2022-166525

Published: 2022

Journal Articles

Correlative Biological Studies Related to the Response, Peak and Persistence of ARI0002h, an Academic BCMA-Directed CAR-T Cell, with Fractionated Initial Infusion and Booster Dose for Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)

Blood (2021) 138 (Supplement 1): 552.

https://doi.org/10.1182/blood-2021-148281

Published: 2021

Journal Articles

Results from a Pilot Study of ARI0002h, an Academic BCMA-Directed CAR-T Cell Therapy with Fractionated Initial Infusion and Booster Dose in Patients with Relapsed and/or Refractory Multiple Myeloma

Blood (2021) 138 (Supplement 1): 2837.

https://doi.org/10.1182/blood-2021-147188

Published: 2021

Journal Articles

CAR Density Influences Antitumoral Efficacy of BCMA CAR-T Cells and Correlates with Clinical Outcome

Blood (2021) 138 (Supplement 1): 735.

https://doi.org/10.1182/blood-2021-148578

Published: 2021

Journal Articles

New Antibcma-CAR for Multiple Myeloma

Lorena Perez Amill, PhD, Guillermo Suñe Rodriguez, PhD, Amer Najjar, PhD, Maria Castella Castella, PhD, Alvaro Urbano-Ispizua, MD, Beatriz Martin-Antonio, PhD

Blood (2017) 130 (Supplement 1): 2062.

https://doi.org/10.1182/blood.V130.Suppl_1.2062.2062

Published: 2017

Journal Articles

Natural Killer Cells Transfer Antimicrobial and Antitumoral Histone H2AZ to Kill Multiple Myeloma Cells Contributing to Transmissible Cytotoxicity

Beatriz Martin-Antonio, PhD, Guillermo Suñe, PhD, Amer Najjar, PhD, Lorena Perez-Amill, Maria Velasco-de Andres, Francisco Lozano, Ester Lozano, Cristina Muñoz-Punedo, Carlos Fernández de Larrea, Alvaro Urbano-Ispizua, MD PhD

Blood (2016) 128 (22): 2115.

https://doi.org/10.1182/blood.V128.22.2115.2115

Published: 2016

Journal Articles

A New Multiple Single-Nucleotide Polymorphisms Based Predictive Model for Grades III to IV and Extensive Graft Versus Host Disease after Identical HLA-Allogeneic Stem-Cell

Blood (2015) 126 (23): 921.

https://doi.org/10.1182/blood.V126.23.921.921

Published: 2015

Journal Articles

Cell-Cell Communication Between Multiple Myeloma (MM) Cells and Cord Blood Derived NK Cells (CB-NK) Regulates Both Tumor Cell Death and Tumor Cell Survival

Beatriz Martin-Antonio, PhD, Erica Serrano, Guillermo Suñe, PhD, Lorena Perez, Marcos Calderón, Jose María Estanyol, PhD, Amer Najjar, PhD, Clara Bueno, PhD, Carlos Fernandez de Larrea, Alvaro Urbano-Ispizua, MD PhD

Blood (2015) 126 (23): 1787.

https://doi.org/10.1182/blood.V126.23.1787.1787

Published: 2015

Journal Articles

Donor and Recipient Genotypes for Interleukin 1 Gene Single Nucleotide Polymorphisms (SNPs) Allow Anticipation of Acute Graft Versus Host Disease after HLA-Identical Allogeneic Stem Cell Transplantation (allo-SCT)

Blood (2014) 124 (21): 666.

https://doi.org/10.1182/blood.V124.21.666.666

Published: 2014

Journal Articles

NK Cells Kill Myeloma Cells By Increasing ER Stress and Decreasing Autophagy Levels. NKG2D and NKP30 Are Involved In These Processes

Beatriz Martin-Antonio, PhD, Amer Najjar, PhD, Simon N. Robinson, PhD, Claude Chew, Li Sufang, Eric Yvon, PhD, Michael W. Thomas, PhD, Katy Rezvani, MD, PhD, Elizabeth J. Shpall, MD, PhD, Nina Shah, MD

Blood (2013) 122 (21): 3487.

https://doi.org/10.1182/blood.V122.21.3487.3487

Published: 2013

Journal Articles

Donor Genotypes For Interleukin-17A Gene Single Nucleotide Polymorphisms (SNPs) Allow Anticipation Of Complications After HLA-Identical Allogeneic Stem Cell Transplantation (allo-SCT)

Blood (2013) 122 (21): 4619.

https://doi.org/10.1182/blood.V122.21.4619.4619

Published: 2013

Journal Articles

A Gene Variant in IRF3 Impacts On the Clinical Outcome of Acute Myeloid Leukemia (AML) Patients Submitted to Allogeneic Stem Cell Transplantation (allo-SCT)

Beatriz Martin-Antonio, Ph.D., Maria Suarez-LLedo, Montserrat Arroyes, Francesc Fernandez-Avilés, Carmen Martinez, MD, Montserrat Rovira, Ildefonso Espigado, MD, PhD, David Gallardo, MD, PhD, Anna Bosch, Ismael Buno, PhD, Carolina Martinez-Laperche, PhD, Antonio Jimenez-Velasco, Rafael De La Camara, MD, Salut Brunet, Jose B. Nieto, Alvaro Urbano-Ispizua, MD/Ph.D

Blood (2012) 120 (21): 468.

https://doi.org/10.1182/blood.V120.21.468.468

Published: 2012

Journal Articles

Mirnas and Gene Expression Profiles in CD34+ Cells Are Dependent On the Source of Progenitor Cells Employed in Transplantation.

Alicia Báez, Beatriz Martin-Antonio, Ph.D., Concepción Prats-Martín, M.D, Isabel Álvarez-Laderas, María Victoria Barbado, Ph.D, Teresa Caballero-Velázquez, Jose Ignacio Piruat, Ph.D, Magdalena Carmona, MD, Jose Antonio Pérez-Simón, Sr., MD, PhD, Alvaro Urbano-Ispizua, MD/Ph.D

Blood (2012) 120 (21): 3020.

https://doi.org/10.1182/blood.V120.21.3020.3020

Published: 2012

Journal Articles

The G-CSF Produces Long-Term Changes in Gene and Mirnas Expression Profiles in CD34+ From Healthy Donors

Alicia Báez, Concepción Prats-Martín, M.D, Isabel Álvarez-Laderas, Estefania Garcia, Luis Ignacio Sanchez-Abarca, Ph.D., Beatriz Martin-Antonio, Ph.D., Alvaro Urbano-Ispizua, MD, Jose Antonio Pérez Simón, MD, PhD

Blood (2012) 120 (21): 588.

https://doi.org/10.1182/blood.V120.21.588.588

Published: 2012

Journal Articles

-52G/A Gene Variant in the β-Defensin-1 ( DEBF1 ) Influences the Development of Severe Acute Graft Versus Host Disease (aGvHD) After Allogeneic Stem Cell Transplantation (Allo-SCT). Functional Association of This Variant with a Low Anti- Inflammatory Response

Beatriz Martin-Antonio, Damià Romero, David Gallardo, MD, PhD, Anna Bosch, Ildefonso Espigado, MD, PhD, Ismael Buno, Carolina Martinez-Laperche, Antonio Jimenez-Velasco, Rafael De La Camara, MD, Salut Brunet, Nieto B Jose, Jose Román, Maria Suarez-LLedo, Francesc Fernandez-Avilés, Carmen Martinez, Montserrat Rovira, Alvaro Urbano-Ispizua, MD

Blood (2011) 118 (21): 3052.

https://doi.org/10.1182/blood.V118.21.3052.3052

Published: 2011

NARROW

CRISPR/Cas9 Multi-Editing Enhances CAR NK Cells Therapeutic Potential Against Multiple Myeloma

Enhanced Antitumoral Efficacy of ARI0002h CAR-T with CD28-TMD in Normal and Low BCMA Expressing Myeloma Cells

ARI0002h (Cesnicabtagene Autoleucel), an Academic Point-of-Care B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor (CAR) T-Cell Strategy: Activity and Safety after Fractionated Initial Therapy and Booster Dose in 60 Patients with Relapsed/Refractory Multiple Myeloma

Bicistronic CAR T Cell Against CD229 and BCMA Effectively Controls Multiple Myeloma

Co-Transduced CD19/BCMA Dual-Targeting CAR-T Cells for the Treatment of Non-Hodgkin Lymphoma

CAR-T Related Cytopenia Profile in Relapsed/Refractory Multiple Myeloma: Results of Patients Treated with ARI0002h, an Academic BCMA-Directed CAR-T Cell

Correlative Biological Studies Related to the Response, Peak and Persistence of ARI0002h, an Academic BCMA-Directed CAR-T Cell, with Fractionated Initial Infusion and Booster Dose for Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)

Results from a Pilot Study of ARI0002h, an Academic BCMA-Directed CAR-T Cell Therapy with Fractionated Initial Infusion and Booster Dose in Patients with Relapsed and/or Refractory Multiple Myeloma

CAR Density Influences Antitumoral Efficacy of BCMA CAR-T Cells and Correlates with Clinical Outcome

New Antibcma-CAR for Multiple Myeloma

Natural Killer Cells Transfer Antimicrobial and Antitumoral Histone H2AZ to Kill Multiple Myeloma Cells Contributing to Transmissible Cytotoxicity

A New Multiple Single-Nucleotide Polymorphisms Based Predictive Model for Grades III to IV and Extensive Graft Versus Host Disease after Identical HLA-Allogeneic Stem-Cell

Cell-Cell Communication Between Multiple Myeloma (MM) Cells and Cord Blood Derived NK Cells (CB-NK) Regulates Both Tumor Cell Death and Tumor Cell Survival

Donor and Recipient Genotypes for Interleukin 1 Gene Single Nucleotide Polymorphisms (SNPs) Allow Anticipation of Acute Graft Versus Host Disease after HLA-Identical Allogeneic Stem Cell Transplantation (allo-SCT)

NK Cells Kill Myeloma Cells By Increasing ER Stress and Decreasing Autophagy Levels. NKG2D and NKP30 Are Involved In These Processes

Donor Genotypes For Interleukin-17A Gene Single Nucleotide Polymorphisms (SNPs) Allow Anticipation Of Complications After HLA-Identical Allogeneic Stem Cell Transplantation (allo-SCT)

A Gene Variant in IRF3 Impacts On the Clinical Outcome of Acute Myeloid Leukemia (AML) Patients Submitted to Allogeneic Stem Cell Transplantation (allo-SCT)

Mirnas and Gene Expression Profiles in CD34+ Cells Are Dependent On the Source of Progenitor Cells Employed in Transplantation.

The G-CSF Produces Long-Term Changes in Gene and Mirnas Expression Profiles in CD34+ From Healthy Donors

-52G/A Gene Variant in the β-Defensin-1 ( DEBF1 ) Influences the Development of Severe Acute Graft Versus Host Disease (aGvHD) After Allogeneic Stem Cell Transplantation (Allo-SCT). Functional Association of This Variant with a Low Anti- Inflammatory Response

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only